MIST
NASDAQ · Pharmaceuticals
Milestone Pharmaceuticals In
$1.92
+0.03 (+1.59%)
Open$1.90
Previous Close$1.89
Day High$1.93
Day Low$1.88
52W High$3.06
52W Low$1.00
Volume—
Avg Volume870.8K
Market Cap222.39M
P/E Ratio—
EPS$-0.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+2,266.1% upside
Current
$1.92
$1.92
Target
$45.43
$45.43
$30.70
$45.43 avg
$53.70
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.13M | 3.15M | 19.07M |
| Net Income | -87,068,455 | -115,885,255 | 5.86M |
| Profit Margin | -4,078.8% | -3,874.8% | 30.7% |
| EBITDA | -85,643,762 | -120,321,759 | 12.52M |
| Free Cash Flow | — | — | 4.46M |
| Rev Growth | -32.4% | -32.4% | +19.4% |
| Debt/Equity | 1.37 | 1.37 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |